For chronic pain sufferers, there is a real problem with the abuse of painkillers in the United States. While the number of patients who have a legitimate need for prescription painkillers — 100 million plus — is vastly more than the number of people addicted to painkillers — 11 million — there is a stigma attached to the prescribing, dispensing and utilization of pain medicines.
Health Media Network and the American College of Cardiology on Wednesday announced a strategic partnership that will significantly increase the size of HMN's Cardiology Network while broadening the distribution of ACC's CardioSmart Initiative.
Nestea on Tuesday announced that it is reviving the "Nestea Plunge" advertising campaign. The overhaul is designed to promote the brand's new recipe, which contains more flavor with fewer calories, according to the brand.
Philips Norelco, an electric shaving and grooming brand, along with baseball All-Star Nick Swisher, are rallying guys across the United States to show support for our military service members by sporting the iconic military haircut — the “High & Tight” — using the new Philips Norelco Hairclipper 7100.
With more women seeking advanced technology in their skin care regimen, beauty brand Philips is bringing its technology to the United States for the first time with the new Philips PureRadiance Facial Cleansing System.
All laundry detergent has extended its All Mighty Pacs and All OXI families with new All Mighty Pacs OXI, pacs formulated with OXI-power stain fighters with triple-play action to fight tough stains, whiten and brighten, according to the company.
CVS Caremark has entered into new clinical affiliations with four regional health systems, representing the first clinical affiliations to include clinical collaborations with MinuteClinic combined with data on interventions performed by CVS pharmacists.
Energizer Personal Care, the makers of Banana Boat brand sunscreen, announced the availability of four new products in mass grocery and drug retailers nationwide, including a formula designed specifically for men.
Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration has approved Pradaxa (dabigatran etexilate mesylate), which is used to treat deep venous thrombosis and pulmonary embolism.
IMS Health Holdings on Thursday announced the pricing of its initial public offering of 65 million shares of its common stock at a price to the public of $20 per share, including 52 million shares to be sold by IMS Health and 13 million shares to be sold by selling shareholders.
AZO Products, a urinary and vaginal health brand for women, announced the launch of AZO Bladder Control with Go-Less. The product serves as a supplement to prescriptions and over-the-counter options and helps optimize normal bladder activity and bladder strength, the company said.